During the past decade, Sunrise Clinical Research, Inc. conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 8 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 2 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sunrise Clinical Research, Inc." #1 sponsor was "Novartis" with 6 trials, followed by "Pfizer" with 6 trials sponsored, "NEMA Research, Inc." with 2 trials sponsored, "OPKO Health, Inc." with 2 trials sponsored and "3EO Health" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sunrise Clinical Research, Inc." #1 collaborator was "Analytical Solutions Group, Inc." with 1 trials as a collaborator, "CTI Clinical Trial and Consulting Services" with 1 trials as a collaborator, "Hexal AG" with 1 trials as a collaborator, "Kelley Medical Consultants LLC" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Sunrise Clinical Research, Inc." are "Alzheimer's Disease" (3 trials), "COVID-19" (3 trials), "Multiple Sclerosis" (3 trials), "Alzheimer Disease" (2 trials) and "COVID-19 Pandemic" (2 trials). Many other conditions were trialed in "Sunrise Clinical Research, Inc." in a lesser frequency.

Most popular intervention types in "Sunrise Clinical Research, Inc." are "Drug" (19 trials), "Other" (4 trials), "Biological" (3 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "PF-07321332" (3 trials), "Ritonavir" (3 trials), "Cesamet™ (nabilone)" (2 trials) and "Placebo Control" (2 trials). Other intervention names were less common.

The vast majority of trials in "Sunrise Clinical Research, Inc." are 25 trials for "All" genders.

Currently, there are NaN active trials in "Sunrise Clinical Research, Inc.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Sunrise Clinical Research, Inc., undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Sunrise Clinical Research, Inc., 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 1 trials that are defined as “Not Applicable".